205 related articles for article (PubMed ID: 18536906)
21. Efficacy and safety of hylan G-F 20 for symptomatic glenohumeral osteoarthritis: a prospective, pilot study.
Brander VA; Gomberawalla A; Chambers M; Bowen M; Nuber G
PM R; 2010 Apr; 2(4):259-67. PubMed ID: 20430327
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of Hylan G-F 20 in shoulder osteoarthritis with an intact rotator cuff. Open-label prospective multicenter study.
Noël E; Hardy P; Hagena FW; Laprelle E; Goebel F; Faure C; Favard L; Gaudin P; Christ R; Baudot C; Dietl J; Goupille P
Joint Bone Spine; 2009 Dec; 76(6):670-3. PubMed ID: 19945321
[TBL] [Abstract][Full Text] [Related]
23. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan.
Wobig M; Bach G; Beks P; Dickhut A; Runzheimer J; Schwieger G; Vetter G; Balazs E
Clin Ther; 1999 Sep; 21(9):1549-62. PubMed ID: 10509850
[TBL] [Abstract][Full Text] [Related]
24. A second course of hylan G-F 20 for the treatment of osteoarthritic knee pain: 12-month patient follow-up.
Waddell DD; Cefalu CA; Bricker DC
J Knee Surg; 2005 Jan; 18(1):7-15. PubMed ID: 15742592
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the therapeutic efficacy of TENS versus intra-articular hyaluronic acid injection in patients with knee osteoarthritis: a prospective randomized study.
Paker N; Tekdös D; Kesiktas N; Soy D
Adv Ther; 2006; 23(2):342-53. PubMed ID: 16751166
[TBL] [Abstract][Full Text] [Related]
26. Total knee replacement delayed with Hylan G-F 20 use in patients with grade IV osteoarthritis.
Waddell DD; Bricker DC
J Manag Care Pharm; 2007 Mar; 13(2):113-121. PubMed ID: 17330972
[TBL] [Abstract][Full Text] [Related]
27. Viscosupplementation for the treatment of osteoarthritis of the knee.
Bellamy N; Campbell J; Robinson V; Gee T; Bourne R; Wells G
Cochrane Database Syst Rev; 2006 Apr; 2006(2):CD005321. PubMed ID: 16625635
[TBL] [Abstract][Full Text] [Related]
28. A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis.
Kotevoglu N; Iyibozkurt PC; Hiz O; Toktas H; Kuran B
Rheumatol Int; 2006 Feb; 26(4):325-30. PubMed ID: 15959784
[TBL] [Abstract][Full Text] [Related]
29. Hylan G-F 20 efficacy on articular cartilage quality in patients with knee osteoarthritis: clinical and MRI assessment.
Cubukçu D; Ardiç F; Karabulut N; Topuz O
Clin Rheumatol; 2005 Aug; 24(4):336-41. PubMed ID: 15599642
[TBL] [Abstract][Full Text] [Related]
30. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee.
Petrella RJ; Petrella M
J Rheumatol; 2006 May; 33(5):951-6. PubMed ID: 16652426
[TBL] [Abstract][Full Text] [Related]
31. A prospective multi-centre, open study of the safety and efficacy of hylan G-F 20 (Synvisc) in patients with symptomatic ankle (talo-crural) osteoarthritis.
Witteveen AG; Giannini S; Guido G; Jerosch J; Lohrer H; Vannini F; Donati L; Schulz A; Scholl J; Sierevelt IN; van Dijk CN
Foot Ankle Surg; 2008; 14(3):145-52. PubMed ID: 19083633
[TBL] [Abstract][Full Text] [Related]
32. Three once-weekly intra-articular injections of Hylan G-F 20 significantly improve pain relief compared with placebo in patients with chronic idiopathic knee osteoarthritis: a single-centre, evaluator-blinded and patient-blinded, randomized controlled trial.
Langworthy M; Lascarides P; Ngai W; Steele K; Huang Y
Drugs Context; 2024; 13():. PubMed ID: 38601838
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis.
Raynauld JP; Goldsmith CH; Bellamy N; Torrance GW; Polisson R; Belovich D; Pericak D; Tugwell P
Osteoarthritis Cartilage; 2005 Feb; 13(2):111-9. PubMed ID: 15694572
[TBL] [Abstract][Full Text] [Related]
34. Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial.
Wang Y; Hall S; Hanna F; Wluka AE; Grant G; Marks P; Feletar M; Cicuttini FM
BMC Musculoskelet Disord; 2011 Aug; 12():195. PubMed ID: 21861935
[TBL] [Abstract][Full Text] [Related]
35. Hylan versus corticosteroid versus placebo for treatment of basal joint arthritis: a prospective, randomized, double-blinded clinical trial.
Heyworth BE; Lee JH; Kim PD; Lipton CB; Strauch RJ; Rosenwasser MP
J Hand Surg Am; 2008 Jan; 33(1):40-8. PubMed ID: 18261664
[TBL] [Abstract][Full Text] [Related]
36. Overall tolerability and analgesic activity of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis.
Theiler R; Brühlmann P
Curr Med Res Opin; 2005 Nov; 21(11):1727-33. PubMed ID: 16307692
[TBL] [Abstract][Full Text] [Related]
37. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone.
Adams ME; Atkinson MH; Lussier AJ; Schulz JI; Siminovitch KA; Wade JP; Zummer M
Osteoarthritis Cartilage; 1995 Dec; 3(4):213-25. PubMed ID: 8689457
[TBL] [Abstract][Full Text] [Related]
38. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results.
Raynauld JP; Torrance GW; Band PA; Goldsmith CH; Tugwell P; Walker V; Schultz M; Bellamy N;
Osteoarthritis Cartilage; 2002 Jul; 10(7):506-17. PubMed ID: 12127830
[TBL] [Abstract][Full Text] [Related]
39. Intraarticular corticosteroid for treatment of osteoarthritis of the knee.
Bellamy N; Campbell J; Robinson V; Gee T; Bourne R; Wells G
Cochrane Database Syst Rev; 2006 Apr; (2):CD005328. PubMed ID: 16625636
[TBL] [Abstract][Full Text] [Related]
40. Efficacy evaluation of highly purified intra-articular hyaluronic acid (Sinovial(®)) vs hylan G-F20 (Synvisc(®)) in the treatment of symptomatic knee osteoarthritis. A double-blind, controlled, randomized, parallel-group non-inferiority study.
Pavelka K; Uebelhart D
Osteoarthritis Cartilage; 2011 Nov; 19(11):1294-300. PubMed ID: 21875678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
